Many of Australia's top brokers have been busy adjusting their financial models again, leading to the release of a number of broker notes this week.
Three ASX shares brokers have named as buys this week are listed below. Here's why they are bullish on them:
Image source: Getty Images
Breville Group Ltd (ASX: BRG)
According to a note out of Goldman Sachs, its analysts have retained their buy rating on this appliance manufacturer's shares with a trimmed price target of $22.70. This follows the release of a half year result which revealed weaker than expected sales but strong gross margins. Overall, the broker believes this result demonstrates Breville's characteristics as a high quality name in a secular growth category and continues to forecast solid earnings growth through to FY 2025. The Breville share price is trading at $20.37 this afternoon.
CSL Limited (ASX: CSL)
A note out of Citi reveals that its analysts have retained their buy rating and lifted their price target on this biotherapeutics company's shares to $350.00. This follows the release of a solid first half result which revealed a faster than expected recovery in plasma collections. The broker was also pleased to see CSL reaffirm its guidance for FY 2023. The CSL share price is fetching $304.83 on Wednesday.
Nanosonics Ltd (ASX: NAN)
Analysts at Morgans have upgraded this infection prevention company's shares to an add rating with a $5.19 price target. The broker believes recent share price volatility has created a buying opportunity for investors. Particularly given its recent trading update that the broker feels demonstrates that Nanosonics' direct sales model is working successfully. The Nanosonics share price is trading at $4.71 on Wednesday afternoon.
